Health care

India OKs AstraZeneca and locally-made COVID-19 vaccines

India authorized two COVID-19 vaccines on Jan. 3, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world's second most populous country.

India's drugs regulator gave an emergency authorization for the vaccines developed by Oxford University and U.K.-based drugmaker AstraZeneca and another developed by the Indian company Bharat Biotech.

Sinopharm Claims 79 Percent Vaccine Efficacy, Seeks Approval for General Use

An affiliate of China's state-owned drug maker Sinopharm said on Wednesday its COVID-19 vaccine showed 79.34% efficacy and it has requested regulatory approval of the shot, moving a step closer to become China's first approved vaccine for general public use.

Kon: We're all against celebrating New Year; 50.000 vaccines to arrive in January

He added that twice as many doses are expected in February.
Kon stated that Serbia expected 340.000 doses of the vaccine in the first quarter, including Chinese and Russian vaccines, but that around 290.000 doses would actually be delivered, because Pfizer fails to deliver all the required quantities.

First batch of coronavirus vaccines arrives in Athens

The first batch of 9,750 anti-coronavirus vaccines arrived at a storage facility in Athens early Saturday morning.

The batch arrived overland; it crossed the border with Bulgaria Friday evening.

These vaccines have been developed by Pfizer-BioΝTech.

The vaccines are stored in special deep-freeze containers, at temperatures between -70 to -80 Celsius.

Vaccination against Covid-19 starting at care homes on Sunday

Ljubljana – Vaccination against Covid-19 is expected to start at care homes around Slovenia on Sunday, Labour Minister Janez Cigler Kralj told the press on Wednesday. According to government Covid-19 spokesman Jelko Kacin, there will be enough vaccine in the first phase for vaccination of all care home residents who have not been infected yet.

Prof. Serbezova: To Say There's no Problem with Medicines in Bulgaria is Cynical

There is a problem with medicines like Clexan and Fraxiparin for example.

There are objective reasons for their absence, but this must be discussed. Neglecting the problem will not solve it.

This was stated in an interview by Prof. Asena Serbezova - Chairwoman of the Bulgarian Pharmaceutical Union.